Ursodeoxycholic acid and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ursodeoxycholic acid (ursodiol) and Risperdal (risperidone). Common drug interactions include anti-cyclic citrullinated peptide antibody positive among females and pneumonia aspiration among males.

The phase IV clinical study analyzes what interactions people have when they take Ursodeoxycholic acid and Risperdal. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ursodeoxycholic acid?

Ursodeoxycholic acid has active ingredients of ursodiol. It is often used in biliary cirrhosis primary. eHealthMe is studying from 7,528 Ursodeoxycholic acid users. Check the latest studies of Ursodeoxycholic acid.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.



On Jul, 27, 2026

19 people who take Ursodeoxycholic acid and Risperdal together, and have interactions are studied.

Ursodeoxycholic acid and Risperdal drug interactions.

What are the common drug interactions of Ursodeoxycholic Acid and Risperdal, by gender? *:

female:

  1. Anti-cyclic citrullinated peptide antibody positive
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Inflammation
  5. Insomnia (sleeplessness)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Pyrexia (fever)
  9. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  10. Abdominal pain

male:

  1. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  2. Blood potassium decreased
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Rectal cancer (cancer of rectum)
  5. Septic shock (shock due to blood infection)
  6. Anaemia (lack of blood)
  7. Blood albumin decreased
  8. Blood bilirubin increased
  9. Drug eruption (adverse drug reaction of the skin)
  10. Gastric ulcer (stomach ulcer)

What are the common drug interactions of Ursodeoxycholic Acid and Risperdal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Rectal cancer (cancer of rectum)
  2. Septic shock (shock due to blood infection)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Anti-cyclic citrullinated peptide antibody positive
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Inflammation
  5. Insomnia (sleeplessness)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Pyrexia (fever)
  9. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  10. Circulatory collapse

60+:

  1. Blood potassium decreased
  2. Cardiac failure
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Anaemia (lack of blood)
  5. Blood albumin decreased
  6. Blood bilirubin increased
  7. Gastric ulcer (stomach ulcer)
  8. Gastroduodenal ulcer
  9. Hepatic failure (liver failure)
  10. Hepatic necrosis (large portions of liver die off due to severe liver disease)

What are the existing conditions these people have? *

  1. Cancer Pain: 3 people, 15.79%
  2. Constipation: 3 people, 15.79%
  3. Insomnia (sleeplessness): 3 people, 15.79%
  4. Gastric Cancer (stomach cancer): 2 people, 10.53%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 10.53%
  6. Partial Seizures With Secondary Generalisation (partial seizure may spread within the brain, a process known as secondary generalization): 2 people, 10.53%
  7. Delirium (wild excitement): 2 people, 10.53%
  8. Urination - Excessive Volume: 1 person, 5.26%
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 5.26%
  10. Ascites (accumulation of fluid in the abdominal cavity): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodeoxycholic acid and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ursodeoxycholic acid and Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ursodeoxycholic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ursodeoxycholic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ursodiol and risperidone (the active ingredients of Ursodeoxycholic acid and Risperdal, respectively), and Ursodeoxycholic acid and Risperdal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: